Hims & Hers Health Inc HIMS shares are rising on Wednesday after BofA Securities and Canaccord Genuity raised their ...
Zacks Investment Research on MSN
Hims & Hers Health, Inc. (HIMS) stock falls amid market uptick: What investors need to know
Hims & Hers Health, Inc. (HIMS) closed at $33.39 in the latest trading session, marking a -1.62% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.18%. Meanwhile, ...
Newsable Asianet News on MSN
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’
The FDA staff’s view clashes with RFK Jr.’s push to deregulate peptides and move more of them toward Category 1 status.
Hims & Hers' stock rebounded from below $14 after a regulatory shock and is now trading above $37 on a diversified growth narrative. Click to learn more.
17d
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership
Barclays expects accelerating revenue and EBITDA growth in the second half of 2026, supported by weight-loss offerings.
Hims & Hers Health (NYSE: HIMS) stock crashed 25% through 10:45 a.m. ET Monday morning after an eventful weekend. Where to invest $1,000 right now? Our analyst team just revealed what they believe are ...
Hims & Hers Health (HIMS) stock, Replimune (REPL) stock, and Capricor (CAPR) stock are in focus as the FDA brings back Advisory Committee meetings. Read more here.
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct ...
Hims & Hers Health announced it will sell Ozempic lookalike pills for $49 a month last week. The FDA objected Friday, and Novo Nordisk sued for patent infringement this morning. Where to invest $1,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results